"CZ - \u010Cesk\u00E1 republika" . "Sl\u00E1ma, Ji\u0159\u00ED" . "Dri\u00E1k, Daniel" . "2" . "Dne 8. \u010Dervna 2006 \u00DA\u0159ad pro potraviny a l\u00E9\u010Diva v USA schv\u00E1lil kvadrivalentn\u00ED vakc\u00EDnu proti HPV typ\u016Fm 6, 11, 16 a 18 jako %22prvn\u00ED a jedinou vakc\u00EDnu proti rakovin\u011B d\u011Blo\u017En\u00EDho \u010D\u00EDpku, cervik\u00E1ln\u00EDm, vulv\u00E1rn\u00EDm a vagin\u00E1ln\u00EDm prekancer\u00F3z\u00E1m zp\u016Fsoben\u00FDm typy 16, 18 a jako prevenci proti bradavic\u00EDm genit\u00E1li\u00ED a n\u00EDzk\u00E9mu stupni cervik\u00E1ln\u00EDch l\u00E9z\u00ED, zp\u016Fsoben\u00FDch typy 6, 11, 16 a 18, pro d\u00EDvky a \u017Eeny ve v\u011Bku 9-26 let%22. V sou\u010Dasn\u00E9 dob\u011B se rutinn\u011B pou\u017E\u00EDvaj\u00ED vakc\u00EDny dv\u011B: kvadrivalentn\u00ED Silgard (Gardasil) a bivalentn\u00ED Cervarix, n\u00E1rodn\u00ED imuniza\u010Dn\u00ED programy v \u0159ad\u011B zem\u00ED praktikuj\u00ED plo\u0161n\u00E9 o\u010Dkov\u00E1n\u00ED, roz\u0161i\u0159uje se indika\u010Dn\u00ED spektrum a doporu\u010Den\u00ED o\u010Dkovat chlapce, horn\u00ED v\u011Bkov\u00E1 hranice nen\u00ED omezena. V n\u011Bkter\u00FDch zem\u00EDch proo\u010Dkovanost naivn\u00ED populace d\u00EDvek dosahuje 80 %, existuj\u00ED data o vysok\u00E9 \u00FA\u010Dinnosti obou vakc\u00EDn proti prekancer\u00F3z\u00E1m d\u011Blo\u017En\u00EDho \u010D\u00EDpku, komunitn\u00ED ochran\u011B p\u0159ed genit\u00E1ln\u00EDmi bradavicemi u Silgardu a roz\u0161\u00ED\u0159en\u00E9 zk\u0159\u00ED\u017Een\u00E9 protekci u Cervarixu. Objevuj\u00ED se prvn\u00ED \u00FAdaje o \u00FA\u010Dinnosti proti karcinom\u016Fm v jin\u00FDch lokalizac\u00EDch. V \u010Cesk\u00E9 republice je od roku 2012 o\u010Dkov\u00E1n\u00ED d\u00EDvek ve v\u011Bku 13-14 let hrazeno ze zdravotn\u00EDho poji\u0161t\u011Bn\u00ED. B\u011Bhem 7 let se p\u0159i pou\u017E\u00EDv\u00E1n\u00ED a srovn\u00E1v\u00E1n\u00ED vakc\u00EDn proti HPV rovn\u011B\u017E objevilo mnoho pochybnost\u00ED, pov\u011Br, zkreslen\u00ED a omyl\u016F. V tomto \u010Dl\u00E1nku byly kontroverzn\u00ED \u00FAdaje aktualizov\u00E1ny podle sou\u010Dasn\u00FDch Souhrn\u016F \u00FAdaj\u016F o p\u0159\u00EDpravku."@cs . . . . "Vaccination against HPV - what we did not know 7 years ago?"@en . "Vakcinologie" . . . "8" . . "O\u010Dkov\u00E1n\u00ED proti HPV - co jsme p\u0159ed 7 lety nev\u011Bd\u011Bli?"@cs . "33850" . "Sehnal, Borek" . . "3"^^ . "[3DAA95EBA70F]" . . . "3"^^ . . "Vaccination against HPV - what we did not know 7 years ago?"@en . . . . "O\u010Dkov\u00E1n\u00ED proti HPV - co jsme p\u0159ed 7 lety nev\u011Bd\u011Bli?" . . "O\u010Dkov\u00E1n\u00ED proti HPV - co jsme p\u0159ed 7 lety nev\u011Bd\u011Bli?" . . "On June 8, 2006, Food and Drug Administration in the USA approved quadrivalent vaccine against HPV 6, 11, 16 and 18 types as %22the first and the one and only vaccine against cervical cancer, cervical, vulvar and vaginal precancerosis caused by HPV 16, 18, and as the prevention against genital warts and cervical laesions of low grade, caused by HPV 6, 11, 16 and 18, for girls and women in the age of 9-26 years%22. At the time, two vaccines are routinely used: quadrivalent Silgard (Gardasil) and bivalent Cervarix. National immunization programmes in many countries practice general vaccination, indications and recommendation for vaccination of boys become broader, maximum age limit has not been set. In some countries vaccination of the na?ve girl's population reaches 80 %, data exist on high efficiency of both vaccines against cervical precancerosis, community protection against genital warts in Silgard and enlarged cross-protection in Cervarix. First data of efficiency against cancers at other localisations also emerge. Since 2012, vaccination of girls at the age of 13-14 years has been covered from the health insurance in the Czech Republic. During 7 years, many doubts, myths, distortions and mistakes in use and comparison of anti-HPV vaccines also appeared. In the paper, the controversial issues were actualized according to the contemporary Summaries of Product's Characteristics."@en . . "RIV/00216208:11110/14:10284552!RIV15-MSM-11110___" . "cross-protection; side-effects; effectiveness; HPV-associated diseases; human papillomavirus; Cervarix; Silgard; vaccines against HPV"@en . "2"^^ . . . . "O\u010Dkov\u00E1n\u00ED proti HPV - co jsme p\u0159ed 7 lety nev\u011Bd\u011Bli?"@cs . "RIV/00216208:11110/14:10284552" . "N" . "1802-3150" . "Dne 8. \u010Dervna 2006 \u00DA\u0159ad pro potraviny a l\u00E9\u010Diva v USA schv\u00E1lil kvadrivalentn\u00ED vakc\u00EDnu proti HPV typ\u016Fm 6, 11, 16 a 18 jako %22prvn\u00ED a jedinou vakc\u00EDnu proti rakovin\u011B d\u011Blo\u017En\u00EDho \u010D\u00EDpku, cervik\u00E1ln\u00EDm, vulv\u00E1rn\u00EDm a vagin\u00E1ln\u00EDm prekancer\u00F3z\u00E1m zp\u016Fsoben\u00FDm typy 16, 18 a jako prevenci proti bradavic\u00EDm genit\u00E1li\u00ED a n\u00EDzk\u00E9mu stupni cervik\u00E1ln\u00EDch l\u00E9z\u00ED, zp\u016Fsoben\u00FDch typy 6, 11, 16 a 18, pro d\u00EDvky a \u017Eeny ve v\u011Bku 9-26 let%22. V sou\u010Dasn\u00E9 dob\u011B se rutinn\u011B pou\u017E\u00EDvaj\u00ED vakc\u00EDny dv\u011B: kvadrivalentn\u00ED Silgard (Gardasil) a bivalentn\u00ED Cervarix, n\u00E1rodn\u00ED imuniza\u010Dn\u00ED programy v \u0159ad\u011B zem\u00ED praktikuj\u00ED plo\u0161n\u00E9 o\u010Dkov\u00E1n\u00ED, roz\u0161i\u0159uje se indika\u010Dn\u00ED spektrum a doporu\u010Den\u00ED o\u010Dkovat chlapce, horn\u00ED v\u011Bkov\u00E1 hranice nen\u00ED omezena. V n\u011Bkter\u00FDch zem\u00EDch proo\u010Dkovanost naivn\u00ED populace d\u00EDvek dosahuje 80 %, existuj\u00ED data o vysok\u00E9 \u00FA\u010Dinnosti obou vakc\u00EDn proti prekancer\u00F3z\u00E1m d\u011Blo\u017En\u00EDho \u010D\u00EDpku, komunitn\u00ED ochran\u011B p\u0159ed genit\u00E1ln\u00EDmi bradavicemi u Silgardu a roz\u0161\u00ED\u0159en\u00E9 zk\u0159\u00ED\u017Een\u00E9 protekci u Cervarixu. Objevuj\u00ED se prvn\u00ED \u00FAdaje o \u00FA\u010Dinnosti proti karcinom\u016Fm v jin\u00FDch lokalizac\u00EDch. V \u010Cesk\u00E9 republice je od roku 2012 o\u010Dkov\u00E1n\u00ED d\u00EDvek ve v\u011Bku 13-14 let hrazeno ze zdravotn\u00EDho poji\u0161t\u011Bn\u00ED. B\u011Bhem 7 let se p\u0159i pou\u017E\u00EDv\u00E1n\u00ED a srovn\u00E1v\u00E1n\u00ED vakc\u00EDn proti HPV rovn\u011B\u017E objevilo mnoho pochybnost\u00ED, pov\u011Br, zkreslen\u00ED a omyl\u016F. V tomto \u010Dl\u00E1nku byly kontroverzn\u00ED \u00FAdaje aktualizov\u00E1ny podle sou\u010Dasn\u00FDch Souhrn\u016F \u00FAdaj\u016F o p\u0159\u00EDpravku." . . . "11110" .